Serotonin and interleukin-6: the role of genetic polymorphisms in IFN-induced neuropsychiatric symptoms.

Marc Udina, José Moreno-España, Ricard Navinés, Dolors Giménez, Klaus Langohr, Mònica Gratacòs, Lucile Capuron, Rafael de la Torre, Ricard Solà, Rocío Martín-Santos
Psychoneuroendocrinology. 2013-09-01; 38(9): 1803-1813
DOI: 10.1016/j.psyneuen.2013.03.007


Read on PubMed

---

1. Psychoneuroendocrinology. 2013 Sep;38(9):1830-1. doi:
10.1016/j.psyneuen.2013.05.019. Epub 2013 Jun 28.

A response to the commentary “Indolamine 2,3-dioxygenase regulation and
neuropsychiatric symptoms” by Loftis, J.M. on “Serotonin and interleukin-6: the
role of genetic polymorphisms in IFN-induced neuropsychiatric symptoms” by Udina,
M., Moreno-España, J., Navinés, R., Gimenez, D., Langohr, K., Gratacòs, M.,
Capuron, L., de la Torre, R., Solà, R., Martin-Santos, R.
http:\dx.doi.org/10.1016/j.psyneuen.2013.03.007.

Udina M(1), Navinés R, Capuron L, Martín-Santos R.

Author information:
(1)Department of Psychiatry and Psychology, Hospital Clínic, IDIBAPS, CIBERSAM,
Spain; Department of Psychiatry and Clinical Psychobiology, University of
Barcelona, Catalonia, Spain.

Comment on
Psychoneuroendocrinology. 2013 Sep;38(9):1803-13.
Psychoneuroendocrinology. 2013 Sep;38(9):1829-30.

DOI: 10.1016/j.psyneuen.2013.05.019
PMID: 23810434 [Indexed for MEDLINE]

Know more about